Primary focal hyperhidrosis: Disease characteristics and functional impairment

Dermatology

Volumn 212, Issue 4, 2006, Pages 343-353

  Hamm, Henning ^a   Naumann, Markus K ^b   Kowalski, Jonathan W ^c   Kütt, Sandra ^a   Kozma, Chris ^d   Teale, Chris ^e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c ALLERGAN INC   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e ALLERGAN PLC   (United States)

Author keywords

Dermatology Life Quality Index; Health related quality of life; Hyperhidrosis; Hyperhidrosis Impact Questionnaire

Indexed keywords

ANTIPERSPIRANT AGENT; BOTULINUM TOXIN; HERBACEOUS AGENT;

ADULT; ARTICLE; AXILLARY HYPERHIDROSIS; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ASSOCIATION; EMOTIONAL DISORDER; FAMILY HISTORY; FEMALE; FUNCTIONAL DISEASE; HEALTH CARE UTILIZATION; HUMAN; HUMAN RELATION; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PALMAR HYPERHIDROSIS; PHYSICAL DISEASE; PREVALENCE; PRIMARY FOCAL HYPERHIDROSIS; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SOCIAL DISABILITY; WELLBEING; WORK DISABILITY;

ADULT; ANALYSIS OF VARIANCE; AXILLA; CASE-CONTROL STUDIES; FEMALE; HAND; HUMANS; HYPERHIDROSIS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SWEAT GLANDS;

EID: 33745727340     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092285     Document Type: Article

References (30)

1. Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe MJ, Naver H, Ahn S, Stolman LP, Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis: Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004;51:274-286.
2. Lonsdale-Eccles A, Leonard N, Lawrence C: Axillary hyperhidrosis: eccrine or apocrine? Clin Exp Dermatol 2003;28:2-7.
3. Swartling C, Naver H, Lindberg M: Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001;8:247-252.
4. Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Legalla G, Gesuita R, Offidani A: Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Clin Ther 2003;25:298-308.
5. Naumann M, Lowe NJ, Kumar CR, Hamm H: Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 2003;139:731-736.
6. Strutton DR, Kowalski JW, Glaser DA, Stang PE: US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-248.
7. Hund M, Kinkelin I, Naumann M, Hamm H: Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol 2002;138:539-541.
8. Lau WT, Lee JD, Dang CR, Lee L: Improvement in quality of life after bilateral transthoracic endoscopic sympathectomy for palmar hyperhidrosis. Hawaii Med J 2001;60:126-137.
9. Swan MC, Paes T: Quality of life evaluation following endoscopic transthoracic sympathectomy for upper limb and facial hyperhidrosis. Ann Chir Gynaecol 2001;90:157-159.
10. Naumann MK, Hamm H, Lowe NJ: Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;147:1218-1226.
11. Tan SR, Solish N: Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 2002;28:495-499.
12. Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis: Prospective, open-label, multicenter, study of Botox (botulinum toxin type A) for the treatment of patients with primary axillary hyperhidrosis: effects on functional impairment and health-related quality of life. Dermatol Surg 2005;31:405-413.
13. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
14. Ware J Jr, Kosinski M, Keller SD: A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
15. Lai YT, Yang LH, Chio CC, Chen HH: Complications in patients with palmar hyperhidrosis treated with transthoracic endoscopic sympathectomy. Neurosurgery 1997;41:110-115.
16. Ro KM, Cantor RM, Lange KL, Ahn SS: Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg 2002;35:382-386.
17. Weber A, Heger S, Sinkgraven R, Heckmann M, Elsner P, Rzany B: Psychosocial aspects of patients with focal hyperhidrosis: marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol 2005;152:342-345.
18. Kurwa HA, Finlay AY: Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995;133:575-578.
19. Badia X, Mascaro JM, Lozano R: Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol 1999;141:698-702.
20. Harlow D, Poyner T, Finlay AY, Dykes PJ: Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000;143:979-982.
21. Jobanputra R, Bachmann M: The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol 2000;39:826-831.
22. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M: Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000;80:430-434.
23. Hahn HB, Melfi CA, Chuang TY, Lewis CW, Gonin R, Hanin MP, Farmer ER: Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. J Am Acad Dermatol 2001;45:44-48.
24. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY: Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-972.
25. Harris A, Burge SM, Dykes PJ, Finlay AY: Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996;135:959-963.
26. Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY: The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997;137:563-567.
27. Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, Fivenson D: Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002;41:151-158.
28. Salmanpoor R, Rahmanian MJ: Treatment of axillary hyperhidrosis with botulinum-A toxin. Int J Dermatol 2002;41:428-430.
29. Poon E, Seed PT, Greaves MW, Kobza-Black A: The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-671.
30. Thompson TR, Belsito DV: Regional variation in prevalence and etiology of allergic contact dermatitis. Am J Contact Dermatitis 2002;13:177-182.